Posts Tagged ‘David Rosenbaum’


As a follow up to Gerbsman Partners “Date Certain M&A” for the sale of the Assets and Intellectual Property of “Palmaz Scientific“, I have outlined below an ‘estimation of the replacement value for Palmaz Scientific’s IP portfolio’ by David G. Rosenbaum, Esq., IP attorney for Palmaz Scientific.



Per our discussion earlier today, in my estimation the replacement value of the debtor-in-possession’s IP portfolio as it currently exists would be between $16,000,000 and $19,000,000. The replacement value represents the cost to recreate the IP portfolio from its inception and in its entirety.

To arrive at this estimate, I first estimated the historical monetary cost of the portfolio to the debtors-in-possession since 1999. This was then adjusted annually for consumer price index changes since 1999.

Rosenbaum IP assists in developing intellectual property assets, formulating and executing strategic intellectual asset plans and positioning the IP portfolios to achieve maximal value for our clients. Our clients have realized over $1.6 Billion (USD) in market value from IP portfolios we have developed over the past fifteen years. This represents an almost 4,400% return on the cost of IP portfolio development and has been recognized through financing rounds, merger and acquisition, licensing or litigation awards. To realize this level of success, we combine legal and technical skills with level-headed business experience and principles. Our practice is exclusively devoted to strategic intellectual property asset development, asset commercialization and IP asset risk management.

Please let me know if you need any further information.


David G. Rosenbaum


UnknownAbout Gerbsman Partners
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property, as well as maximizing value for Intellectual Property Patents. Since 2001, Gerbsman Partners has been involved in maximizing value for 91 technology, medical device, life science, solar, fuel cell, cyber security and digital marketing companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A Transactions.

Gerbsman Partners has offices and strategic alliances in San Francisco, New York, McLean, VA/Washington DC, Orange County, Boston, Europe and Israel.

Read Full Post »